title: The prevalence of tardive dyskinesia in fluphenazine-treated patients.
abstract: One hundred thirty-five outpatients were evaluated for tardive dyskinesia (TD). Of the fluphenazine-treated patients (N = 63), 32 were found to have TD as compared with 29 of 72 non-fluphenazine-treated patients. This difference was not statistically significant. There was no difference in duration and total dose of fluphenazine injections between TD and non-TD patients. However, patients receiving fluphenazine injections were found to require fewer hospitalizations after fluphenazine therapy was started.
authors.affiliation: Douglas Hospital Centre, Verdun, Québec, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Yassa
authors.forename: H
authors.initials: H
authors.lastname: Iskandar
authors.forename: J
authors.initials: J
authors.lastname: Ally
mesh_terms: D000375:Aging / Q000502:physiology; D000978:Antiparkinson Agents / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000978:Antiparkinson Agents; D005476:Fluphenazine